Cliniphai pairs intelligent systems
with human expertise

Vladimir Mats is Co-founder and CEO of Cliniphai, with more than 25 years of experience in statistical analysis and clinical data management across the pharmaceutical, biotechnology, and medical device industries.

He previously co-founded Quartesian, a global clinical research organization (CRO), and served as Senior Vice President at Veranex. Vladimir holds a PhD in Biostatistics from the University of Maryland, Baltimore, making him instrumental in advancing Cliniphai’s mission.

Jason Martin is the Co-Founder & Chairman of Cliniphai, bringing over 30 years of experience in pharmaceutical R&D, clinical research, and data science. He currently serves as Vice President, Digital Technologies at NAMSA, and has held senior roles at Signant Health, Parexel, Medidata, and Amgen, driving innovation in clinical trial technology.

He holds a MS in Chemistry from the University of California, Berkeley and a dual executive MBA from Columbia University and London Business School.

Yuri Kartashov is Co-Founder and R&D Advisor at Cliniphai, with more than 20 years of experience in software development, technology leadership, and innovation management.

He currently serves as Vice President of Data Management and Analytics at Veranex and has held senior positions at Quartesian, the Euclid Research Center, and CSC Risk Institute, among others. Yuri holds a PhD in Mathematics, Probability Theory, and Statistics from Taras Shevchenko National University of Kyiv, as well as  certifications in deep learning and data science.

Donna Wallace is the Chief Compliance Officer at Cliniphai, bringing over 20 years of experience in clinical trial quality systems, compliance, and operational excellence. Previously Head of Quality at Medidata, Donna has led global initiatives across pharma, biotech, and health tech to strengthen regulatory alignment and inspection readiness.

At Cliniphai, she oversees enterprise-wide compliance strategy and ensures that every AI-driven workflow meets the highest standards of data integrity, transparency, and global regulatory expectations.

Don F. McLean is the Chief Marketing & Communications Officer at Cliniphai, where he leads brand strategy, messaging, and market engagement across the AI-powered platform. With a background in public relations, life sciences marketing, and executive thought leadership, Don has helped launch and grow some of the most innovative companies in clinical research and health tech.

At Cliniphai, he drives positioning that resonates with sponsors, CROs, and technology partners. Don holds an MBA in Marketing Management from Madonna University. 

Formerly a top-level executive with Medidata, CARET Legal and Fresh Direct, Arbitman brings decades of experience in product strategy, FDA-regulated systems, and Agile program delivery, and will lead execution across Athena’s growing marketplace environment

With over 25 years of experience in information technology and resource management, Slava is a seasoned technology leader known for delivering complex projects on time and within budget. His career spans startups, mid-size firms, and large enterprises, always focused on building high-performing engineering teams and fostering innovation.

At Cliniphai, Slava oversees our technology vision and leads the engineering, QA, and infrastructure teams to ensure secure, scalable, and efficient delivery of our AI-powered solutions for life sciences.